Mainz BioMed N.V. | WebDisclosure

Basculer en Français

10886	Companies
236948	Keywords
165838	Articles
127159	Press releases

Home
Companies
Mainz BioMed N.V.

PRESS RELEASE

published on 07/25/2024 at 14:01, 2 years 1 month ago

Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience
Mainz Biomed launches enhanced ColoAlert test with new features to improve screening efficiency and user experience. The updates aim to optimize colorectal cancer detection

ColoAlert Mainz Biomed Colorectal Cancer Screening Efficiency Enhanced Test
BRIEF

published on 07/09/2024 at 09:06, 2 years 1 month ago

Mainz Biomed Submits for FDA Breakthrough Device Designation for CRC Screening Test

Mainz Biomed Colorectal Cancer FDA Submission Breakthrough Device Screening Test
BRIEF

published on 07/09/2024 at 09:06, 2 years 1 month ago

Mainz Biomed soumet une demande de désignation de dispositif révolutionnaire par la FDA pour le test de dépistage du CRC

Cancer Colorectal Mayence Biomed Soumission À La FDA Appareil Révolutionnaire Test De Dépistage
PRESS RELEASE

published on 07/09/2024 at 09:01, 2 years 1 month ago

Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test
Mainz Biomed N.V. seeks FDA Breakthrough Device Designation for Next Generation CRC Screening Test with impressive clinical results

Mainz Biomed N.V. Colorectal Cancer MRNA Biomarkers FDA Breakthrough Device Designation Next Generation CRC Screening Test
BRIEF

published on 07/02/2024 at 14:06, 2 years 1 month ago

Mainz Biomed Provides Half Year 2024 Corporate Update

Diagnostic Solutions FDA Approval Mainz Biomed Colorectal Cancer Half Year Results
BRIEF

published on 07/02/2024 at 14:06, 2 years 1 month ago

Mainz Biomed fournit une mise à jour d'entreprise pour le semestre 2024

Résultats Semestriels Cancer Colorectal Mayence Biomed Approbation De La FDA Solutions De Diagnostic
PRESS RELEASE

published on 07/02/2024 at 14:01, 2 years 1 month ago

Mainz Biomed Provides Half Year 2024 Corporate Update
Mainz Biomed N.V. provides corporate update for the first half of 2024, showcasing industry-leading clinical data and strategic partnerships. Expect half-year financial results in September 2024

Strategic Partnerships Corporate Update Clinical Data Mainz Biomed N.V. Half-year Financial Results
BRIEF

published on 06/03/2024 at 14:06, 2 years 2 months ago

Mainz Biomed Unveils Industry-Leading Study Results at ASCO 2024

Mainz Biomed MRNA Biomarkers ASCO 2024 CRC Detection Multimodal Screening
BRIEF

published on 06/03/2024 at 14:06, 2 years 2 months ago

Mainz Biomed dévoile les résultats d'une étude de pointe à l'ASCO 2024

Mayence Biomed Biomarqueurs D'ARNm ASCO 2024 Détection CRC Dépistage Multimodal
PRESS RELEASE

published on 06/03/2024 at 14:01, 2 years 2 months ago

Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
Mainz Biomed presented industry-leading results of its pooled study at ASCO 2024, demonstrating high sensitivity in detecting colorectal cancer and precancerous lesions using mRNA biomarkers and AI algorithm

Mainz Biomed Colorectal Cancer MRNA Biomarkers ASCO 2024 Precancerous Lesions

Accesswire

Published on 08/27/2026 at 02:35, 1 hour 56 minutes ago

Galantas Gold Reports Second Quarter 2026 Results
Published on 08/27/2026 at 02:00, 2 hours 31 minutes ago

Algo Grande Copper Announces Upsizing of Private Placement
Published on 08/27/2026 at 00:05, 4 hours 26 minutes ago

Kidoz Reports Record Q2 2026 Revenue, up 37%, as H1 Revenue Reaches US$6.28 Million (CAD$8.66 Million)
Published on 08/26/2026 at 23:00, 5 hours 31 minutes ago

Datametrex Announces Transition to Semi-Annual Financial Reporting
Published on 08/26/2026 at 22:30, 6 hours 1 minute ago

AI/ML Innovations Inc. Closes First Tranche of Private Placement

View all ACCESSWIRE

EQS Group

Published on 08/27/2026 at 03:00, 1 hour 31 minutes ago

Hong Kong Fashion Fest presents eight flagship programmes for its third edition
Published on 08/26/2026 at 23:05, 5 hours 26 minutes ago

Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
Published on 08/26/2026 at 18:44, 9 hours 47 minutes ago

AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
Published on 08/26/2026 at 18:40, 9 hours 51 minutes ago

MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
Published on 08/26/2026 at 18:30, 10 hours 1 minute ago

Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China

Les Echos

Published on 08/26/2026 at 18:02, 10 hours 29 minutes ago

Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:02, 10 hours 29 minutes ago

Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial
Published on 08/26/2026 at 18:00, 10 hours 31 minutes ago

Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/26/2026 at 18:00, 10 hours 31 minutes ago

Altarea : Conclusion d’un accord global mettant fin au litige entre Altarea et les actionnaires du groupe Praemia (ex-groupe Primonial)
Published on 08/26/2026 at 18:00, 10 hours 31 minutes ago

KLARSEN : lance Dimea, sa nouvelle activité e-commerce dédiée aux compléments alimentaires

View all LES ECHOS COMFI WIRE